Literature DB >> 11701972

Paradominant inheritance may explain familial occurrence of Cutis marmorata telangiectatica congenita.

R Danarti1, R Happle, A König.   

Abstract

Cutis marmorata telangiectatica congenita (CMTC) is a rare congenital vascular anomaly that virtually always occurs sporadically and in a patchy, quadrant, unilateral or otherwise segmental manifestation. This would suggest mosaicism of a postzygotic mutation. Some authors, however, described CMTC occurring in several members of a family. This paradox may be explained by the concept of paradominant inheritance. Heterozygous individuals carrying a 'paradominant' mutation are, as a rule, phenotypically normal. The mutation can therefore be transmitted unperceived through many generations. The trait only becomes manifest when a postzygotic mutation occurring during early embryogenesis gives rise to loss of heterozygosity and forms a mosaic population of cells being either homozygous or hemizygous for the mutation. This concept may explain the occasional familial occurrence of CMTC. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2001        PMID: 11701972     DOI: 10.1159/000051750

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  3 in total

1.  Cutis marmorata telangiectatica congenita with gangrenous ulceration and hypovolaemic shock.

Authors:  I-Jan Hu; Ming-Ting Chen; Hao-Chih Tai; Po-Nien Tsao; Hung-Chieh Chou; Wu-Shiun Hsieh
Journal:  Eur J Pediatr       Date:  2005-04-06       Impact factor: 3.183

Review 2.  EphrinB2-EphB4-RASA1 Signaling in Human Cerebrovascular Development and Disease.

Authors:  Xue Zeng; Ava Hunt; Sheng Chih Jin; Daniel Duran; Jonathan Gaillard; Kristopher T Kahle
Journal:  Trends Mol Med       Date:  2019-02-25       Impact factor: 11.951

3.  Cutis marmorata telangiectatica congenita and aberrant Mongolian spots: Type V phacomatosis pigmentovascularis or phacomatosis cesiomarmorata.

Authors:  Guilian Du; Xiaomin Zhang; Tangde Zhang
Journal:  JAAD Case Rep       Date:  2016-01-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.